Givaudan stock faces US price-fixing trial after court ruling
Published on 11/12/2026 at 12:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSCourt ruling keeps litigation active
- A New Jersey federal judge found that plaintiffs had adequately alleged horizontal price-fixing under US antitrust laws.
- The ruling allows the claims to continue toward a possible trial but does not establish liability or damages for Givaudan.
- The case could keep legal costs, potential remedies and management attention in focus as proceedings continue.
Givaudan faces continued legal pressure in the United States after a federal judge allowed claims alleging price-fixing in fragrance ingredients to proceed toward a possible trial. The ruling concerns a procedural stage of the case and does not determine whether Givaudan or other defendants are liable.
Court ruling keeps litigation active
Judge William J. Martini of the US District Court for the District of New Jersey issued the opinion on Monday, November 9, according to Bloomberg Law. He denied the defendants' motion for judgment on the pleadings after finding that plaintiffs, including businesses and consumers, had adequately alleged price-fixing under the Sherman Act and state antitrust laws.
The judge said the alleged conduct should be assessed as horizontal price-fixing between competitors at the same market level. That classification keeps the claims alive in the litigation and may allow the case to advance toward trial. It is not a finding that Givaudan inflated prices.
For investors, the ruling extends the period in which potential litigation costs, remedies and management time may remain relevant. The financial outcome is not established by the decision, and the proceedings do not by themselves quantify any possible exposure for Givaudan.
Givaudan stock traded at 4,430.00 euros on Lang & Schwarz at 12:21 CET on Thursday, November 12, 2026.
Givaudan stock facts
- Company: Givaudan S.A.
- ISIN: CH0010645932
- Ticker: GIVN.SW
- Home exchange: SIX Swiss Exchange
- Lang & Schwarz price: 4,430.00 euros at 12:21 CET on November 12, 2026
European investors are also watching the Swiss market through the SMI index.
More news and analyses on Givaudan stock will follow as the US proceedings develop.
